Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

When leukemia was first identified

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Leukemia was discovered because the blood itself looked wrong. Before microscopes were turned on blood, there was no way to see it at all.

The story runs from a Paris autopsy in 1827 to a drug designed against a specific broken gene in 2001, which is a fast two centuries by the standards of medicine.

Related pages: Leukemia (blood cancer)

The bottom line

What we know
  • The first clinical description is usually credited to Alfred Velpeau in 1827.
  • Bennett and Virchow independently described the disease in 1845.
  • Virchow introduced the name leukemia, from the Greek for white blood, in 1847.
  • The first temporary remissions in childhood leukemia were achieved by Sidney Farber in 1947 and 1948.
What is still open
  • How many earlier deaths were leukemia described as something else entirely.
  • Whether the apparent rise in childhood leukemia through the twentieth century was real or an artefact of better diagnosis.

The story, step by step

  1. 1. 1827 ()
  2. 2. 1845 ()
  3. 3. 1847 to 1913 ()
  4. 4. 1947 to 1960 ()
  5. 5. 1960 to now ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

A patient in Paris, and blood full of pus

Review of many studies

What happens

The first description that is generally accepted as leukemia came from the French surgeon Alfred Velpeau.

What the research shows

  • His patient had a hugely enlarged abdomen, fever and weakness, and died shortly after admission.
  • At autopsy the spleen and liver were enormous and the blood appeared thick, which Velpeau described as resembling pus.
  • He had no way to know what he was looking at. The cellular theory of disease did not yet exist.
  • Other similar cases were reported over the following two decades without being recognized as one disease.

Why it matters

The disease was found at the exact moment the tools to see it arrived, which is true of a great deal of nineteenth-century medicine.

What's still uncertain

  • Retrospective diagnosis from a nineteenth-century case report is inherently uncertain.

Read more

Next: 1845

Part 2 of 5

Two descriptions, six weeks apart

Review of many studies

What happens

In 1845 the disease was described properly, twice, by people who did not know of each other's work.

What the research shows

  • In Edinburgh, John Hughes Bennett reported a case of enlarged spleen and liver in which he concluded death was caused by a suppuration of the blood.
  • Six weeks later in Berlin, Rudolf Virchow, then in his mid-twenties, published his own account under the title Weisses Blut, white blood.
  • Bennett thought it was pus and therefore an infection. Virchow argued it was not pus but a genuine excess of the blood's own colourless cells.
  • Virchow was right, and his interpretation is the one that led somewhere.

Why it matters

The disagreement was not about what they saw but about what it meant, and getting the interpretation right is what turned an observation into a disease.

What's still uncertain

  • A contemporaneous case was also reported by David Craigie in the same journal issue as Bennett's.

Read more

Next: 1847 to 1913

Part 3 of 5

A name, then a classification

Review of many studies

What happens

The name came two years after the description, and the useful subdivisions took another sixty years.

What the research shows

  • In 1847 Virchow coined leukamie, from the Greek leukos, white, and haima, blood. The word is unchanged today.
  • In 1872 Ernst Neumann showed the disease originates in the bone marrow, not the spleen as had been assumed.
  • Paul Ehrlich's staining methods in the late 1870s made it possible to tell white cell types apart under a microscope, which is what made classification possible at all.
  • By 1913 leukemia was being separated into acute and chronic, and lymphoid and myeloid, the same two axes still used today.

Why it matters

The classification that organizes every modern treatment decision was in place before any treatment existed.

What's still uncertain

  • Early classifications were based entirely on appearance, and some categories were later revised once genetics became available.

Read more

Next: 1947 to 1960

Part 4 of 5

The first remissions, and the first chromosome

Review of many studies

What happens

Two discoveries, a decade apart, created modern oncology.

What the research shows

  • In Boston, Sidney Farber reasoned that if folate helps blood cells divide, blocking it might stop leukemic cells. He tested aminopterin, an antifolate, in children with acute leukemia.
  • In 1948 he reported temporary remissions in several children. They were brief and all the children relapsed, but no one had ever produced a remission at all.
  • Farber wrote that there was now some justification for real hope in what had been a hopeless disease. He was right, though it took decades.
  • In 1960 Peter Nowell and David Hungerford, in Philadelphia, found a consistently abnormal small chromosome in chronic myeloid leukemia cells.
  • The Philadelphia chromosome was the first chromosomal abnormality ever consistently linked to a human cancer. In 1973 Janet Rowley showed it was a translocation between chromosomes 9 and 22.

Why it matters

Farber's remissions established that chemotherapy could work. The Philadelphia chromosome established that cancer is a genetic disease. Both ideas started here.

What's still uncertain

  • Farber's trials were conducted in an era with no formal consent standards, and that history is part of how modern research ethics developed.

Read more

Next: 1960 to now

Part 5 of 5

Combinations, then targets, then cells

Review of many studies

What happens

The rest follows from those two ideas.

What the research shows

  • Combination chemotherapy in the 1960s and 1970s, particularly at St Jude under Donald Pinkel, raised childhood ALL survival from almost nothing toward the majority.
  • Bone marrow transplantation was developed through the 1960s and 1970s, work recognized with a Nobel Prize for E. Donnall Thomas in 1990.
  • ATRA, and later arsenic trioxide, turned acute promyelocytic leukemia from the most lethal acute leukemia into the most curable.
  • Imatinib, approved in 2001, was designed against the protein the Philadelphia chromosome produces, 41 years after it was found.
  • CAR-T therapy was first approved for relapsed B-cell ALL in 2017, the first gene therapy of its kind approved in the United States.

Why it matters

The gap between finding the Philadelphia chromosome and drugging it was four decades. That interval is a fair measure of how long translation really takes.

What's still uncertain

  • Survival gains have been much larger in children than in older adults, and that gap has not closed.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.